Initiation of cardiac allograft rejection New developments in cellular and molecular mechanisms.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Trends in cardiovascular medicine

• Publication date

  1993-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/1050-1738(93)90006-RPMID 21244933
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Mechanism for the Antiinflammatory Effects of Corticosteroids

  1993cited by this paper
• The interleukin 2 CD28-responsive complex contains at least three members of the NF kappa B family: c-Rel, p50, and p65.

  1993cited by this paper
• Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1.

  1992cited by this paper
• Vascular cell adhesion molecule-1 is induced on endothelium during acute rejection in human cardiac allografts.

  1992cited by this paper
• The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation.

  1992cited by this paper
• Blocking of mononuclear cell accumulation, cytokine production, and endothelial activation within rat cardiac allografts by CD4 monoclonal antibody therapy.

  1992cited by this paper
• A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1.

  1992cited by this paper
• FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin

  1992cited by this paper
• Cytokine expression and endothelial cell and lymphocyte activation in human cardiac allograft rejection: an immunohistochemical study of endomyocardial biopsy samples.

  1992cited by this paper
• Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation

  1992cited by this paper
• Expression of cell adhesion molecules in human cardiac allograft rejection.

  1992cited by this paper
• Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg.

  1992cited by this paper
• Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene.

  1992cited by this paper
• T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo.

  1992cited by this paper
• PROLONGATION OF ALLOGRAFT AND XENOGRAFT SURVIVAL IN MICE BY ANTI‐CD2 MONOCLONAL ANTIBODIES

  1992cited by this paper
• The mechanism of action of cyclosporin A and FK506.

  1992cited by this paper
• Alloantigenicity of human endothelial cells. 1. Frequency and phenotype of human T helper lymphocytes that can react to allogeneic endothelial cells.

  1992cited by this paper
• Functional analysis of the human vascular cell adhesion molecule 1 promoter

  1992cited by this paper
• Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements

  1992cited by this paper
• Structure and chromosomal location of the gene for endothelial-leukocyte adhesion molecule 1.

  1991cited by this paper
• Regulation of T cell receptor signaling by a src family protein-tyrosine kinase (p59fyn).

  1991cited by this paper
• The role of vascular endothelial cells in transplantation.

  1991cited by this paper
• Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A

  1991cited by this paper
• Myocyte Injury and Contraction Abnormalities Produced by Cytotoxic T Lymphocytes

  1991cited by this paper
• Signal requirements for the generation of CD4+ and CD8+ T-cell responses to human allogeneic microvascular endothelium.

  1991cited by this paper
• CD4 monoclonal antibodies in organ transplantation--a review of progress.

  1991cited by this paper
• Activation of endothelial-leukocyte adhesion molecule 1 (ELAM-1) gene transcription.

  1991cited by this paper
• A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation.

  1991cited by this paper
• T-cell receptor-negative natural killer cells display antigen-specific cytotoxicity for microvascular endothelial cells.

  1990cited by this paper
• Immunologic aspects of rejection.

  1990cited by this paper
• Adhesion receptors of the immune system

  1990cited by this paper
• The Endothelial Cell as a Regulator of T‐Cell Function

  1990cited by this paper
• Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts.

  1990cited by this paper
• Coclustering CD45 with CD4 or CD8 alters the phosphorylation and kinase activity of p56lck

  1990cited by this paper
• In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts.

  1990cited by this paper
• Anti-CD4 monoclonal antibody administration in renal transplanted patients.

  1990cited by this paper
• The molecular basis of alloreactivity.

  1990cited by this paper
• Regulation of major histocompatibility complex class-II genes: X, Y and other letters of the alphabet.

  1990cited by this paper
• Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link.

  1990cited by this paper
• Evidence that cytotoxic lymphocytes alter and traverse allogeneic endothelial cell monolayers.

  1989cited by this paper
• Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes.

  1989cited by this paper
• Signal transduction through the CD4 receptor involves the activation of the internal membrane tyrosine-protein kinase p56lck

  1989cited by this paper
• Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X.

  1988cited by this paper
• The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck.

  1988cited by this paper
• Mechanisms of monoclonal antibody‐facilitated tolerance induction: a possible role for the CD4 (L3T4) and CD11a (LFA‐1) molecules in self‐non‐self discrimination

  1988cited by this paper
• A multiplicity of CCAAT box-binding proteins.

  1987cited by this paper
• CD4 monoclonal antibody pairs for immunosuppression and tolerance induction

  1987cited by this paper
• Lymphocyte subsets differentially induce class II human leukocyte antigens on allogeneic microvascular endothelial cells.

  1987cited by this paper
• Phenotypic and functional characterization of lymphocytes that bind human microvascular endothelial cells in vitro. Evidence for preferential binding of natural killer cells.

  1987cited by this paper
• Effector mechanisms in allograft rejection.

  1986cited by this paper
• Induction of tolerance by monoclonal antibody therapy

  1986cited by this paper
• Administration of F(ab')2 fragments of monoclonal antibody to L3T4 inhibits humoral immunity in mice without depleting L3T4+ cells.

  1986cited by this paper
• Massive induction of donor-type class I and class II major histocompatibility complex antigens in rejecting cardiac allografts in the rat

  1985cited by this paper
• Vascular endothelial cell HLA-DR antigen and myocyte necrosis in human allograft rejection.

  1985cited by this paper
• IDENTIFICATION OF THE ANTIBODY TO VASCULAR ENDOTHELIAL CELLS IN PATIENTS UNDERGOING CARDIAC TRANSPLANTATION

  1985cited by this paper
• The lymphocyte subpopulations in cyclosporine-treated human heart rejection.

  1985cited by this paper
• Increase of natural killer cells in rejecting kidney grafts.

  1984cited by this paper
• A controlled serial ultrastructural tracer study of first-set cardiac allograft rejection in the rat. Evidence that the microvascular endothelium is the primary target of graft destruction.

  1983cited by this paper
• Are “natural killer” cells involved in allograft rejection?

  1983cited by this paper
• Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon

  1983cited by this paper
• Glucocorticoid-induced inhibition of T cell growth factor production. II. The effect on the in vitro generation of cytolytic T cells.

  1979cited by this paper
• Glucocorticoid-induced inhibition of T cell growth factor production. I. The effect on mitogen-induced lymphocyte proliferation.

  1979cited by this paper

• Masterclass Immune effector mechanisms in heart transplant rejection

  2007cites this paper
• In vivo pharmacological effects of ciclosporin and some analogues.

  1996cites this paper
• Lysis of adult ventricular myocytes by cells infiltrating rejecting murine cardiac allografts.

  1996cites this paper
• Evolution of focal moderate (International Society for Heart and Lung Transplantation grade 2) rejection of the cardiac allograft.

  1996cites this paper
• Response to Salmonella enteritidis infection by the immunocompromised avian host.

  1995cites this paper
• Mechanisms of immune-mediated myocyte injury.

  1994cites this paper
• Functional Changes in the Intact Heart During Immune-Mediated Injury

  year unknowncites this paper